Mirataz (mirtazapine ointment) is a transdermal medication specifically developed and FDA-approved to manage undesired weight loss in cats—a leading cause of visits to the veterinarian for cats. Mirataz, which is formulated with KindredBio's proprietary Accusorb technology, is applied topically to the cat's inner ear (pinna) once a day, providing a more convenient application route than oral administration. Mirataz is a serotonin and histamine receptor antagonist that has demonstrated body weight gain in cats experiencing weight loss. The product is classified as a weight gain drug and can be used in cats with various underlying diseases associated with unintended weight loss.

1555 Bayshore Hwy, Suite 200 Burlingame, CA 94010
Tel: (650) 701-7901